Hypertension is a highly prevalent and critical risk factor in metabolic syndrome, necessitating lifestyle and pharmacologic interventions to reduce cardiovascular and renal morbidity.
No takes yet. Share an insight, caveat, or question.
Supports BP screening in metabolic syndrome without diabetes; leaves open whether this alters outcomes in prospective trials.
Stanley S. Franklin (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: